Jonathan Wosen, PhD

Jonathan Wosen is a freelance science journalist who holds a PhD in immunology from Stanford University. He has written for STAT News, Stanford University School of Medicine, the Santa Cruz Sentinel, and Genetic Engineering & Biotechnology News. Jonathan is currently enrolled in the UC Santa Cruz Science Communication Program.

All articles by Jonathan Wosen, PhD

The new risk score, developed by Emory researchers, could be a useful tool for determining overall and progression-free survival after immunotherapy.

Renal Cell Carcinoma

Risky Business: A New Scoring System for Metastatic Renal Cell Carcinoma

By

Jonathan Wosen, PhD

February 11, 2020

The new risk score, developed by Emory researchers, could be a useful tool for determining overall and progression-free survival after immunotherapy.

FDA analyses find trial-to-trial variation in the analysis of patient reported outcomes, underscoring the need for standardization.

FDA Studies Assess Patient-Reported Outcomes in Lung Cancer Trials

By

Jonathan Wosen, PhD

November 25, 2019

FDA analyses find trial-to-trial variation in the analysis of patient reported outcomes, underscoring the need for standardization.

Next post in Lung Cancer

A Call for Improving the Quality of Cancer Care in Geriatric Patients

Elderly, Non-Hispanic Blacks Less Likely to Receive Guideline-Concordant Treatment for Lung Cancer